| 注册
首页|期刊导航|中国药业|大鼠体内清金固本胶囊中橙皮苷药代动力学分析

大鼠体内清金固本胶囊中橙皮苷药代动力学分析

李娜 李玎 陈萍

中国药业2017,Vol.26Issue(24):1-4,4.
中国药业2017,Vol.26Issue(24):1-4,4.DOI:10.3969/j.issn.1006-4931.2017.24.001

大鼠体内清金固本胶囊中橙皮苷药代动力学分析

Pharmacokinetic Analysis of Hesperidin from Qingjin Guben Capsules in Rat Serum

李娜 1李玎 1陈萍2

作者信息

  • 1. 陕西中医药大学,陕西咸阳712046
  • 2. 陕西省中医药研究院,陕西西安710003
  • 折叠

摘要

Abstract

Objective To establish an HPLC method for content determination of hesperidin in rat serum after oral administration Qingjin Guben Capsules,and its pharmacokinetics in rats were also studied.Methods SD rats were given the Qingjin Guben Capsules by gavage,the blood was collected at different time,and the supernatant was separated and detected by adding methanol to precipitate protein.HPLC was used to determine hesperidin in rat serum,the mobile phase was 0.1% phosphoric acid aqueous solution(A)-70% acetonitrle(B) for gradient elution,the detection wavelength was 283 nm.DAS 2.1.1 software was used to calculate phannacokinetic parameters.Results The linear range of hesperidin was 0.1-1.1 μg/mL(r =0.996 4),the quantitative lower limit was 0.1 μg/mL,the recovery rate of the method was 94.76%-101.55%,and the result of stability test was good.The main pharmacokinetic parameters of hesperidin in rat serum were as follows:Tmax was (1.00±0.31) h,Cmax was (0.53 ±0.09) mg/L,AUC0 t was (1.40±0.03) mg/(L · h),AUC0-∞ was (2.05 ±0.29) mg/(L · h) and t1/2β was (68.10± 13.12) h.Conclusion The method is simple,rapid and sensitive,which is suitable for the pharmacokinetic study of Qingjin Guben Capsules.

关键词

清金固本胶囊/橙皮苷/高效液相色谱法/药代动力学/大鼠

Key words

Qingjin Guben Capsules/hesperidin/HPLC/pharmacokinetics/rat

分类

医药卫生

引用本文复制引用

李娜,李玎,陈萍..大鼠体内清金固本胶囊中橙皮苷药代动力学分析[J].中国药业,2017,26(24):1-4,4.

基金项目

陕西省自然科学基础研究计划项目[13-LC128]. ()

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文